Experimental pancreatic cancer pill doubles survival chances, boosts quality of life
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Daraxonrasib reduced the overall risk of death by 60 per cent compared with chemotherapy.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial…
Erleada reduced the risk of the cancer spreading or death by 20 per cent. Grouped from 2 articles across 2 sources.
Patients on ivonescimab lived longer by four months compared with those on immunotherapy.
WorkSafe charges Northern Territory Health with failing to comply with health and safety duties over the death of a mental health in-patient at Royal Darwin Hospital in 2022.
The ACT government unveils details of the new North Canberra Hospital as part of its latest budget, with the total cost of the project now expected to be $1.5 billion.
The deaths of two children who had been left in cars during hot weather were the result of their parents' memory failure, a NSW coroner finds.